Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Topical Betaxolol for the Prevention of Retinopathy of Prematurity

NCT01660620 is registered in ClinicalTrials.gov with Smith-Kettlewell Eye Research Institute as lead sponsor.

NCT NCT01660620
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01660620 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Topical Betaxolol for the Prevention of Retinopathy of Prematurity
Lead sponsor
Smith-Kettlewell Eye Research Institute
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2011
Completion date
November 30, 2011
Enrollment
23 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

development of side effects from betaxolol